We are live on ! Find out more
LOACR

Longevity Acquisition Corporation Right
LOACR

Delisted

LOACR was delisted on the 19th of March, 2021.

8 hedge funds and large institutions have $460K invested in Longevity Acquisition Corporation Right in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 4 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 88 (0)

21% less capital invested

Capital invested by funds: $579K → $460K (-$119K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
4
Closed
Calls
Puts
Net Calls
Net Calls Change

LOACR Hedge Fund Activity: Q3 2019 in Review

8 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Longevity Acquisition Corporation Right (LOACR) for Q3 2019, worth a combined $460K — down 21% from $579K a quarter earlier.

Fund positioning in LOACR was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 4 trimmed.

The largest seller was Oxford Asset Management, cutting an estimated $21.7K.

  • 8 institutional investors held Longevity Acquisition Corporation Right (LOACR) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $460K of Longevity Acquisition Corporation Right stock for Q3 2019, down 21% quarter-over-quarter.
  • 0 funds opened new Longevity Acquisition Corporation Right positions in Q3 2019 and 0 closed out.
  • The largest Longevity Acquisition Corporation Right seller in Q3 2019 was Oxford Asset Management, an estimated $21.7K sold.

Based on aggregated 13F filings for Q3 2019.